TELLS US WHY SOME ELECTION DAY POLLING SITES HAD TO MOVE THIS YEAR. >> MARRIAGE HONOR AND ROLE FOR ONE HOSPITAL IN THE WORLDWIDE EFFORT TO DEVELOP THERAPEUTICS FOR COVID-19. MOORE REGIONAL IN PINE HURT IS TAKING PART IN A NEW CLINICAL TRIAL COMBINING REMDESIVIR FROM PEOPLE WHO HAVE DONATED PLASMA, TO COLLECT ANTIBODIES. NOW MOORE VOLCANO THE FIRST HOSPITAL IN THE WORLD TONE ROLL A PATIENT IN THE TRIAL WHICH OFFICIALLY BEGAN LAST THURSDAY. PATIENTS WHO ARE NOT RECEIVING THE PLACEBO WILL RECEIVE A ONE- TIME HIGH-DOSE INFUSION OF ANTIBODIES GIVEN ON THE FIRST DAY OF THE FIVE-DAY TREATMENT OF REMDESIVIR. ALL PATIENTS THEN GET REGULAR FOLLOW UPS FOR 28 DAYS. IN THIS SOUNDS FAMILIAR, IT'S A SIMILAR TREATMENT PLAN PRESIDENT TRUMP SAID DURING HIS BOUT WITH COVID-19. IT'S A DIFFERENT TYPE OF ANTIBODY, HOWEVER. THE PRINCIPAL INVESTIGATOR TOLD ME HIS OUTCOME WAS STILL ENCOURAGING FOR THEIR PLAN. >> THE WAY THAT IT'S TRUE PRODUCE SAD LITTLE DIFFERENT THAN WHAT WE'RE DOING, BUT THE GENERAL IDEA IS THE SAME. THE GENERAL IDEA OF GIVING HIGH DOSE OF AN ANTIBODY DIRECTED AGAINST COVID-19 AND THAT WE KNOW NEUTRALIZES THE VIRUS, BUT THAT'S THE SAME PREMISE FOR BOTH TREATMENTS. >> THEY HOPE TO ENROLL MORE PATIENTS AT MOORE REGIONAL TRIAL. THE NIH IS RECRUITING 500 IN TOTAL AT HOSPITAL AROUND THE WORLD. ON A LIGHTER NOTE, THOUGH, STAFF AT MOORE REGIONAL GOT QUITE THE SURPRISE WHILE ON A CONFERENCE CALL WITH NIH. TAKE A LISTEN. >> THEY SAID WE HAD ONE OTHER PERSON WHO WAS GOING TO SAY SOMETHING, AND IT WAS DR. ANTHONY FAUCI, JUST CONGRATULATING THE TEAM ON ALL OF OUR HARD WORK, AND IT WAS A REALLY BIG MOMENT FOR ALL OF THE PEOPLE HERE AT FIRST HEALTH. WE WERE QUITE SURPRISED AND THERE WAS A LITTLE JUMPING UP